Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it ...

Staphylococcus aureus infections remain a formidable health threat, responsible for the most infection-related deaths ...

More than 100 students at Binzhou vocational college in East China's Shandong Province have been diagnosed with norovirus ...

Norovirus treatment exerts a significant burden on Veterans Health Administration (VHA) spending, totalling $28 million in costs when extrapolated annually. That is according to an October study ...